Market Context and Recent Performance of Apeloa Pharmaceutical
Apeloa Pharmaceutical Co., Ltd. (000739.SZ) closed the trading session on Friday, 23 October 2026, with its share price unchanged, registering a 0 % movement over the 24‑hour period that concluded at 04:28 PM Central European Time. At the time of writing, one share of Apeloa is trading at approximately CNY 19.65 on the Shenzhen Stock Exchange. The company’s current float is 1.2 billion shares, and its market capitalisation stands at CNY 24.5 billion. Within the preceding 24 hours, approximately CNY 266.6 million worth of shares changed hands.
Since the end of the previous month, Apeloa’s share price has declined by 17.54 %. Its 200‑day simple moving average (SMA) is located at CNY 20.46, indicating that the stock is trading below its long‑term trend. The most recent 52‑week high of the share reached CNY 28.50 on 10 August 2026, while the low of the same period was CNY 14.92 on 5 November 2025.
Industry‑Wide Dynamics
The downward pressure on Apeloa’s stock price reflects a broader pullback in the innovative‑drug and contract‑research‑organization (CRO) sector. The company’s shares fell by more than ten percent, joining peers such as HEBO Medical, BAI PUSI, and PLUO Medical, all of which recorded significant losses amid heightened market volatility. This sectoral decline coincided with a notable dip in the U.S. biotechnology market; for instance, Moderna, a prominent biotechnology firm, closed lower by over ten percent. The collective movement suggests a shift in investor sentiment toward more cautious positioning within the pharmaceutical and biotech space.
Comparative Performance of Related Stocks
| Stock | Ticker | 24‑hour Move | Current Price | Market Capitalisation | P/E Ratio |
|---|---|---|---|---|---|
| Beijing Roborock Technology | 688169.SS | 0 % | CNY 112.46 | CNY 27 bn | 19.54 |
| Cgn Power –H | 1816.HK | 0 % | HKD 3.28 | HKD 31.7 bn | 14.59 |
| Dazhong Mining Co. | 001203.SZ | 0 % | CNY 18.23 | CNY 29.1 bn | 43.24 |
| Grandit | 688549.SS | 0 % | CNY 17.44 | CNY 27.1 bn | – |
| Tianjin Pharmaceutical (T14.SI) | T14.SI | –2.62 % | USD 2.56 | USD 4.1 bn | 16.19 |
While Apeloa’s share price stagnated, several of its peers either held steady or experienced modest declines. Beijing Roborock Technology’s new G‑Rover robot has yet to enter production, and the company continues to assess market conditions and regulatory compliance in the United States. Cgn Power –H and Dazhong Mining Co. remain largely unchanged, whereas Tianjin Pharmaceutical experienced a slight dip, mirroring the broader cautious sentiment in the pharmaceutical sector.
Company Profile
Apeloa Pharmaceutical Co., Ltd. is headquartered in Dongyang, China, and specializes in the manufacturing and marketing of raw‑material medicines and preparations. Its product portfolio spans antitumour, antiviral, anti‑infectious, cardiovascular, and other therapeutic categories. The company went public on 9 May 1997, and its shares are listed on the Shenzhen Stock Exchange. More detailed information about Apeloa’s products and corporate strategy can be found on its website at www.apeloa.com .
